Endothelial-monocyte activating polypeptides (EMAPs): tumor derived mediators which activate the host inflammatory response.
Kao
J
J
Department of Physiology and Cellular Biophysics, Columbia University, College of Physicians and Surgeons, New York, NY 10032.
Fan
Y G
YG
Haehnel
I
I
Clauss
M
M
Stern
D
D
D000818:Animals; D016207:Cytokines; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology*; D006801:Humans; D007249:Inflammation / Q000503:physiopathology*; D008070:Lipopolysaccharides / Q000633:toxicity; D009000:Monocytes / Q000187:drug effects / Q000502:physiology*; D009363:Neoplasm Proteins / Q000494:pharmacology / Q000502:physiology*; D009369:Neoplasms / Q000098:blood supply*; D009374:Neoplasms, Experimental / Q000098:blood supply / Q000473:pathology / Q000648:ultrastructure; D016601:RNA-Binding Proteins; D013927:Thrombosis / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology / Q000502:physiology*
D016207:Cytokines; D008070:Lipopolysaccharides; D009363:Neoplasm Proteins; D016601:RNA-Binding Proteins; D014409:Tumor Necrosis Factor-alpha; C077219:small inducible cytokine subfamily E, member 1